Skip to main content

Table 3 Family planning counseling by client, provider, and facility characteristics

From: Quality of care in family planning services in Senegal and their outcomes

  

Family planning counseling

  

Counseling on how to use method, side effects, and when to returna

How to use methoda

Side effectsb

When to returnb

Method protects from STIa

Variable

Category

%

p-value

%

p-value

%

p-value

%

p-value

%

p-value

Client’s age

  

0.170

 

0.115

 

0.176

 

0.005

 

0.074

14–24

22.5

 

69.1

 

33.4

 

47.8

 

13.1

 

25–39

15.9

 

59.8

 

25.7

 

33.6

 

8.1

 

40–58 or don’t know

17.1

 

62.1

 

31.6

 

31.9

 

4.5

 

Client’s education

  

0.046

 

0.092

 

0.245

 

0.111

 

0.288

No education

13.9

 

58.4

 

25.8

 

32.7

 

6.8

 

Primary & post primary

22.2

 

66.5

 

29.9

 

40.5

 

10.8

 

Secondary or more

21.0

 

67.0

 

33.6

 

42.4

 

11

 

Client status

  

<0.001

 

<0.001

 

<0.001

 

<0.001

 

<0.001

New client

38.1

 

89.2

 

53.9

 

60.8

 

18.1

 

Returning client

8.9

 

50.8

 

18.0

 

27.0

 

4.8

 

Contraceptive method used

  

0.013

 

<0.001

 

0.001

 

<0.001

 

0.547

Pills

15.6

 

77.0

 

22.2

 

26.8

 

7.1

 

Progestin-only injection

16.0

 

54.8

 

27.6

 

37.4

 

9.0

 

IUD or implantsc

29.0

 

70.3

 

45.2

 

54.5

 

11.4

 

Provider category

  

0.586

 

0.186

 

0.592

 

0.707

 

0.063

Nurse or nurse assistant

16.4

 

58.1

 

26.9

 

38.4

 

13.1

 

Midwife and other

18.5

 

64.7

 

29.5

 

36.5

 

6.8

 

Provider sex

  

0.955

 

0.158

 

0.789

 

0.257

 

0.039

Male

18.1

 

56.3

 

27.4

 

42.7

 

16.1

 

Female

17.8

 

64.0

 

29.0

 

35.9

 

7.2

 

Provider years of education

  

0.972

 

0.513

 

0.401

 

0.770

 

0.267

6–12

18.4

 

52.9

 

37.7

 

31.8

 

2.3

 

13–16

18.2

 

64.0

 

29.8

 

36.7

 

10.3

 

17+

17.3

 

62.0

 

25.3

 

38.8

 

7.7

 

Provider training in family planning in the past 24 months

  

0.644

 

0.789

 

0.740

 

0.394

 

0.862

No

17.1

 

61.9

 

28.0

 

35.3

 

9.1

 

Yes

18.8

 

63.2

 

29.5

 

39.3

 

8.6

 

Provider activities supervised

  

0.646

 

0.127

 

0.277

 

0.125

 

0.105

None

20.4

 

65.4

 

34.3

 

38.2

 

7.0

 

1–5

15.5

 

55.9

 

23.9

 

43.4

 

5.3

 

6

18.2

 

65.3

 

29.1

 

33.2

 

11.7

 

Provider has a job description

  

0.814

 

0.478

 

0.803

 

0.618

 

0.550

No

17.3

 

60.7

 

28.0

 

38.4

 

7.8

 

Yes

18.2

 

64.0

 

29.2

 

36.2

 

9.6

 

Provider salary type

  

0.346

 

0.340

 

0.740

 

0.532

 

0.003

Monthly or daily salary

19.3

 

64.5

 

29.8

 

38.6

 

11.7

 

No regular salary but other compensation

17.1

 

61.5

 

27.1

 

35.1

 

4.8

 

None

10.7

 

53.8

 

25.7

 

32.8

 

1.4

 

Health facility type

  

0.138

 

0.583

 

0.077

 

0.120

 

0.169

Hospital/health center

13.9

 

64.4

 

22.7

 

31.5

 

5.9

 

Health post

18.8

 

62.2

 

30.1

 

38.5

 

9.6

 

Locality

  

0.295

 

<0.001

 

0.225

 

0.524

 

0.263

Urban

19.7

 

70.1

 

31.3

 

35.8

 

7.1

 

Rural

15.8

 

54.4

 

25.8

 

38.6

 

10.7

 

Region

  

0.545

 

<0.001

 

0.179

 

0.010

 

0.339

Northern

11.7

 

49.1

 

19.6

 

29.2

 

4

 

Dakar

17.2

 

77.0

 

30.5

 

28.0

 

8.6

 

Thiès

24.3

 

64.0

 

40.1

 

39.0

 

8.9

 

Central

17.5

 

44.6

 

26.8

 

49.4

 

8

 

East

24.0

 

43.1

 

34.6

 

26.9

 

7.3

 

South

18.8

 

78.6

 

25.7

 

48.0

 

16

 

General structure equipment composite index

  

0.127

 

0.373

 

0.093

 

0.005

 

0.842

Low

13.3

 

64.7

 

23.1

 

28.5

 

7.8

 

Medium

21.8

 

64.9

 

34.7

 

41.6

 

10

 

High

20.2

 

58.1

 

30.7

 

44.2

 

8.4

 

Total

 

17.9

 

62.6

 

28.7

 

37.1

 

8.9

 
  1. aApplies to all users, only ten respondents reported using methods other than pill, injectable, IUD, or implant
  2. bOnly applies to users of pill, injectable, IUD, and implant
  3. cIncludes 10 respondents who used other methods, which were male condoms, LAM, and counseling on periodic abstinence
  4. Note: Bold values indicate a p-value<0.05